MEDS: TRxADE Market Price to Net Income Ratio

Corporate emblem and logo of TRxADE HEALTH Inc (MEDS)

The asset value tracked on the GURU.Markets chart for TRxADE HEALTH, Inc. (MEDS) is 0.00, illustrating the company's price action. The business relies on resilient demand within the pharmacy sector, although crises may limit clinic IT spending. TRxADE HEALTH, Inc. (MEDS) attracts talent through flexible scheduling and stock options, establishing a digital standard for pharmacy services. The software-based nature of the service ensures profit growth as transaction volumes increase due to minimal marginal costs.

TRxADE HEALTH Inc (MEDS) - Price to Earnings Ratio from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for TRxADE (MEDS)

- current price and projected stock value:
Summary company analysis:MEDS (trxadehealth.com)
Core merchandise of trxadehealth.com

Investors determine an asset's investment attractiveness through the ratio of market value to actual yield. This coefficient is calculated by dividing market capitalization by net profit, measuring the payback period of the investment. For TRxADE HEALTH (MEDS), this reflects the monetization efficiency of its digital pharmaceutical marketplace and telemedicine services. The business's margin dynamics are clearly captured in the company's estimated P/E. Analyzing this chart allows for the timely identification of unjustified price optimism.

Competing companies

Price to Earnings Multiple VEEV (veeva.com)|Price to Earnings Ratio DOCS (Doximity)|Market Price to Net Income Ratio HQY|Price to Earnings Ratio Waystar Inc. WAY|Company Value to Net Income CRVL|PRVA: Price to Earnings Ratio|HURN (huronconsultinggroup.com) - Price to Earnings Multiple|CERT: P/E Multiple|Omnicell Inc (OMCL) - P/E Multiple|GDRX (GoodRx Corp) - P/E Multiple|Price to Earnings Multiple SDGR (Schrodinger Corp)|P/E Multiple PHR|OMDA - Market Cap to Earnings|Evolent Health - Price to Earnings Ratio|Company Value to Net Income HSTM|Definitive Healthcare Inc. - P/E Multiple|Company Value to Net Income CCSI (Consensus Corp)|AGL: P/E Multiple|Market Cap to Earnings absci.com (ABSI)|SY (So-Young International Inc.) - P/E Multiple|P/E Multiple National Research Corp|Price to Earnings Ratio Spok Corp (SPOK)|Price to Earnings Ratio OPRX (OptimizeRx Inc.)|TruBridge, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio SLP (simulations-plus.com)|SOPHiA GENETICS S.A. - P/E Multiple|Company Value to Net Income HCAT (Health Catalyst Inc.)|CCLD (carecloud.com) - Price to Earnings Ratio|Research Solutions Inc. - Company Value to Net Income|DLHC (DLH Corp) - P/E Multiple|OneMedNet Corp. (ONMD) - Business Payback Period|Price to Earnings Ratio Scienture (SCNX)|Healthcare Triangle Inc - Price to Earnings Multiple|P/E Multiple ISPC (iSpecimen)|BFRG - Price to Earnings Ratio|WORX: Price to Earnings Ratio|Business Payback Period msprecovery.com MSPR|icoreconnect.com (ICCT) - Price to Earnings Ratio|Price to Earnings Ratio Orgenesis Inc|RCM (R1 RCM, Inc.) - P/E Multiple|Market Cap to Earnings Sharecare Inc SHCR|P/E Multiple STRM|syrahealth.com - Price to Earnings Multiple|Price to Earnings Ratio Apollo Medical Holdings, Inc. AMEH|Business Payback Period Model N Inc (MODN)|NextGen - P/E Multiple